Facioscapulohumeral Muscular Dystrophy Market In the year 2021, the total prevalent cases of FSHD were 78,790 in the 7MM which are expected to grow during the study period, i.e., 2019–2032. The Facioscapulohumeral Muscular Dystrophy therapeutics market is anticipated to grow … Continue reading →

MULTIPLE SCLEROSIS MARKET The Multiple Sclerosis Market is expected to strengthen as awareness of the disease increases and more effective interventions are being developed. The Multiple Sclerosis (MS) market dynamics are anticipated to change in the coming years owing to … Continue reading →

Dermatomyositis Market Nonpharmacological therapies, like exercise and physical therapy, are essential to managing dermatomyositis. It helps improve muscle strength, mobility, and function. DelveInsight’s “Dermatomyositis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical … Continue reading →

Duchenne Muscular Dystrophy Pipeline Insight Several major pharma and biotech companies such as Sarepta Therapeutics, PTC Therapeutics, Nippon Shinyaku, Pfizer, Santhera Pharmaceuticals/ReveraGen BioPharma, Taiho Pharmaceutical, FibroGen, Capricor, Daiichi Sankyo, Italfarmaco, Antisense Therapeutics, Solid Biosciences, among others, are actively working in … Continue reading →

Acute Myeloid Leukemia Market Acute Myeloid Leukemia Market has a promising outlook, with several emerging therapies in various stages of clinical development. The overall dynamics of the Acute Myeloid Leukemia market are anticipated to change in the coming years owing … Continue reading →

Multiple System Atrophy Market Outlook 2032 In 2022, the market size of Multiple System Atrophy was highest in the US among the 7MM accounting for approximately USD 131 million that is further expected to increase by 2032. The Multiple System … Continue reading →